| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $47.7M | -6.2% |
| R&D Expense | $17.5M | +2.5% |
| SG&A Expense | $52.9M | -1.1% |
| Operating Income | -$42.1M | -21.3% |
| Interest Expense | $6.6M | -34.8% |
| Pre-tax Income | -$54.4M | +22.9% |
| Income Tax | $0 | — |
| Net Income | -$54.4M | +22.9% |
| EPS (Basic) | -$1.12 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Inventory | $5.8M | +43.1% |
| Current Assets | $39.9M | -15.6% |
| Total Assets | $57.1M | -7.9% |
| Current Liabilities | $39.5M | +80.0% |
| Total Liabilities | $175.6M | +21.9% |
| Stockholders' Equity | -$118.6M | -44.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.8M | +70.3% |
| Capital Expenditures | $1.0M | +12.2% |
| Investing Cash Flow | -$2.5M | -176.5% |
| Financing Cash Flow | $11.6M | -61.6% |
| Free Cash Flow | -$10.8M | +68.1% |
| +39.5% |
| EPS (Diluted) | -$1.12 | +39.5% |